Darrell Morgan will be a key leader in the Dunedin office.
Darrell Morgan.
Cancer diagnostics company Pacific Edge (NZX, ASX: PEB) hasd announced the appointment of Darrell Morgan as chief operating officer.
Morgan has extensive experience in senior leadership and executive roles in large, mid-sized and virtual pharmaceutical companies in the UK, Europe, and New Zealand. He has more than 37 years’ experience in pharmaceutical R&D, immunodiagnostics and device development for drug delivery across human and animal health, in R&D, technical operations and customer-facing roles.
As COO, Morgan will be a key leader in the Dunedin office, and responsible for Pacific Edge’s global laboratory operations, manufacturing, logistics, inventory management, the quality and regulatory compliance functions, and operationalising people and culture initiatives. He will have a focus on project management, people and culture, and operational excellence.
Morgan will join Pacific Edge on October 3 and report to chief executive Dr Peter Meintjes as a member of the C-Suite team. He will be based in Dunedin.
Since 2013, Morgan has been a senior leader with animal health company Argenta Research where his roles have included global head of pharmaceutical sciences, VP customer relationships – pharmaceutical sciences, and product development director – technical operations. Prior to Argenta Research, he worked for global biopharmaceutical company UCB in the UK for eight years in senior roles with a focus on sterile drug product and medical device development.
Meintjes said: “We are delighted to welcome Darrell to Pacific Edge. His experience in global organisations of varied sizes in a range of roles focused on product and service delivery will be of great value to Pacific Edge and its partners and customers as we continue to drive increased adoption of our suite of Cxbladder diagnostics.”
Morgan said: “I have been impressed by the strong momentum I have seen from Pacific Edge as it expands globally, with a focus on the US. I look forward to working with the team to ensure quality and scale continues as the company grows.”
Morgan is a chartered biologist, with postgraduate diplomas in industrial pharmaceutical sciences and management, people, and change.
This is supplied content and not commissioned or paid for by NBR.
